Direxion Daily S&P Biotech Bull 3x Shares Rating $94.24 +4.45 (+4.96%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.76Holdings in LABU have an aggregate rating of Moderate Buy based on 647 analyst ratings issued in the past year covering 40 companies (41.4% of the portfolio).LABU Aggregate Price Target$94.24High Prediction$94.24Average Prediction$94.24Low Prediction$94.24Holdings in LABU have an aggregate price target of $94.24 and a range of $94.24 to $94.24 covering 40 companies (41.4% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 LABU Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.04%NTRANatera$161.88+2.4%2.0775 of 5 stars3.00$152.67 -5.7%15Positive NewsGap DownHigh Trading Volume1.75%INCYIncyte$68.84+2.7%4.7061 of 5 stars2.35$76.29 10.8%20Analyst ForecastHigh Trading Volume1.72%GILDGilead Sciences$92.57+1.6%4.483 of 5 stars2.67$96.43 4.2%27Insider TradeHigh Trading Volume1.66%UTHRUnited Therapeutics$359.58-0.2%4.7048 of 5 stars2.73$370.86 3.1%15Analyst DowngradeInsider TradeHigh Trading Volume1.56%NBIXNeurocrine Biosciences$135.42+0.3%4.8318 of 5 stars2.83$166.00 22.6%23Analyst ForecastInsider TradeHigh Trading Volume1.56%SRPTSarepta Therapeutics$118.97-0.4%4.8162 of 5 stars2.91$178.71 50.2%22Analyst Forecast1.47%INSMInsmed$70.44+1.5%2.9603 of 5 stars3.00$83.67 18.8%16Insider TradeHigh Trading Volume1.46%VRTXVertex Pharmaceuticals$397.27+0.2%4.7468 of 5 stars2.52$499.77 25.8%31Analyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume1.45%ALNYAlnylam Pharmaceuticals$245.44+2.8%4.416 of 5 stars2.71$298.09 21.5%24Analyst Upgrade1.43%EXASExact Sciences$59.40+5.9%4.5271 of 5 stars2.94$72.94 22.8%181.42%ABBVAbbVie$175.58+2.4%4.937 of 5 stars2.88$205.70 17.2%24Analyst ForecastInsider TradeHigh Trading Volume1.28%BIIBBiogen$146.47-0.6%4.6279 of 5 stars2.45$242.68 65.7%29Analyst DowngradeHigh Trading Volume1.28%MDGLMadrigal Pharmaceuticals$308.44+5.1%4.2404 of 5 stars2.69$347.33 12.6%13Positive News1.27%AMGNAmgen$263.38+0.8%4.4622 of 5 stars2.40$319.67 21.4%25Analyst DowngradeGap UpHigh Trading Volume1.17%VKTXViking Therapeutics$42.25+1.8%4.2972 of 5 stars3.15$106.75 152.7%13Analyst ForecastGap Up1.16%BMRNBioMarin Pharmaceutical$65.66+1.0%4.9844 of 5 stars2.74$94.20 43.5%23Positive NewsHigh Trading Volume1.07%TGTXTG Therapeutics$32.20+4.0%4.3111 of 5 stars2.83$40.67 26.3%6Analyst DowngradePositive News1.06%CRSPCRISPR Therapeutics$40.72+0.8%2.5514 of 5 stars2.44$77.93 91.4%18Analyst ForecastHigh Trading Volume1.02%BPMCBlueprint Medicines$90.14+1.4%2.5363 of 5 stars2.65$123.33 36.8%20Insider Trade1.00%REGNRegeneron Pharmaceuticals$701.85-0.9%4.6634 of 5 stars2.70$1,052.90 50.0%23Analyst ForecastHigh Trading Volume0.98%MRNAModerna$39.39-0.4%4.2751 of 5 stars2.14$79.50 101.8%22Analyst DowngradeHigh Trading Volume0.97%CYTKCytokinetics$48.87+4.6%4.1477 of 5 stars2.75$84.07 72.0%16Analyst Forecast0.81%HALOHalozyme Therapeutics$46.96-0.8%4.9904 of 5 stars2.60$61.11 30.1%10Analyst ForecastPositive NewsHigh Trading Volume0.80%KRYSKrystal Biotech$164.83+2.5%4.5154 of 5 stars3.00$206.67 25.4%8Analyst ForecastHigh Trading Volume0.78%RVMDRevolution Medicines$44.06+1.8%4.4792 of 5 stars3.09$65.82 49.4%11Insider Trade0.74%RNAAvidity Biosciences$31.82+2.5%2.1835 of 5 stars3.00$64.36 102.3%11Analyst ForecastInsider TradeAnalyst RevisionNews CoverageHigh Trading Volume0.73%ROIVRoivant Sciences$11.57+0.6%2.85 of 5 stars2.88$17.93 55.0%8Insider TradeHigh Trading Volume0.71%EXELExelixis$33.29-1.2%4.5006 of 5 stars2.50$32.44 -2.6%18Analyst DowngradeAnalyst RevisionHigh Trading Volume0.69%ADMAADMA Biologics$17.40-2.8%3.7789 of 5 stars3.25$21.25 22.1%4Positive NewsGap Down0.67%ALKSAlkermes$29.71-0.9%4.6622 of 5 stars2.58$35.42 19.2%12Positive NewsHigh Trading Volume0.65%APLSApellis Pharmaceuticals$33.21+0.2%4.5696 of 5 stars2.70$49.94 50.4%20Analyst Downgrade0.64%IONSIonis Pharmaceuticals$35.63+0.1%4.4264 of 5 stars2.68$60.65 70.2%19Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageHigh Trading Volume0.63%TWSTTwist Bioscience$47.94+9.9%2.5563 of 5 stars2.70$51.90 8.3%10High Trading Volume0.58%BBIOBridgeBio Pharma$26.49+1.1%4.6977 of 5 stars2.86$47.69 80.0%14High Trading Volume0.55%BHVNBiohaven$36.26+2.6%3.7245 of 5 stars3.07$63.00 73.7%14Analyst ForecastHigh Trading Volume0.53%PCVXVaxcyte$86.53+0.4%1.5904 of 5 stars3.00$145.71 68.4%8Analyst ForecastInsider TradeHigh Trading Volume0.53%IOVAIovance Biotherapeutics$7.38+2.2%4.0316 of 5 stars2.89$22.33 202.6%90.52%SWTXSpringWorks Therapeutics$35.59+2.3%2.0071 of 5 stars3.00$69.50 95.3%60.52%GERNGeron$3.49-4.6%3.8526 of 5 stars3.09$7.15 104.9%11Short Interest ↓High Trading Volume0.50%CRNXCrinetics Pharmaceuticals$53.60+1.6%4.0769 of 5 stars3.00$74.40 38.8%10Positive NewsHigh Trading Volume This page (NYSEARCA:LABU) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LABU Stock Alerts